SPOTLIGHT -
Panelists round out their review of staging and risk stratification in CSCC by considering how each affects the selection of optimal surgical strategies.
BET Inhibition Highlights Exploration of Novel Targeted Approaches in Myelofibrosis
CSCC Experts Discuss Considerations for Determining Resectable Disease and Translating Data Into Practice
Retrospective Findings Show Younger Age of LGBTQI+ Patients at Time of Diagnosis
Chen Discusses Diagnosis, Management, and Disparities in Cutaneous T-cell Lymphoma
Targeted Therapy Developed in FCS Clinical Trials Transforming Cancer Treatment For Adult Patients with Diffuse Large B-cell Lymphoma
Optimizing CSCC Management Requires a Multifaceted Approach to Care
Medicaid Expansion Improves Survival in Pancreatic, Gastric Cancers, Potentially Reducing Disparities
Telephone-Based Weight Loss Program Is Effective for Breast Cancer Survivors
Pembrolizumab Plus Chemo With or Without Bevacizumab Maintains OS Benefit in Frontline Cervical Cancer
Minimally Invasive Distal Pancreatectomy Provides Effective Alternative in Resectable Pancreatic Cancer